APA

Patton J. T., Lustberg M. E., Lozanski G., Garman S. L., Towns W. H., Drohan C. M., Lehman A., Zhang X., Bolon B., Pan L., Kinghorn A. D., Grever M. R., Lucas D. M. & Baiocchi R. A. (20151203). The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease. : Oncotarget.

Chicago

Patton John T, Lustberg Mark E, Lozanski Gerard, Garman Sabrina L, Towns William H, Drohan Callie M, Lehman Amy, Zhang Xiaoli, Bolon Brad, Pan Li, Kinghorn A Douglas, Grever Michael R, Lucas David M and Baiocchi Robert A. 20151203. The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease. : Oncotarget.

Harvard

Patton J. T., Lustberg M. E., Lozanski G., Garman S. L., Towns W. H., Drohan C. M., Lehman A., Zhang X., Bolon B., Pan L., Kinghorn A. D., Grever M. R., Lucas D. M. and Baiocchi R. A. (20151203). The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease. : Oncotarget.

MLA

Patton John T, Lustberg Mark E, Lozanski Gerard, Garman Sabrina L, Towns William H, Drohan Callie M, Lehman Amy, Zhang Xiaoli, Bolon Brad, Pan Li, Kinghorn A Douglas, Grever Michael R, Lucas David M and Baiocchi Robert A. The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease. : Oncotarget. 20151203.